|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 253/30 | |
| C07C 255/47 | |||
| C07D 221/22 | |||
| C07D 317/30 | |||
| C07C 317/44 |
| (11) | Number of the document | 1383733 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02701498.4 |
| Date of filing the European patent application | 2002-03-04 | |
| (97) | Date of publication of the European application | 2004-01-28 |
| (45) | Date of publication and mention of the grant of the patent | 2008-03-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2002/000660 |
| Date | 2002-03-04 |
| (87) | Number | WO 2002/085843 |
| Date | 2002-10-31 |
| (30) | Number | Date | Country code |
| 285131 P | 2001-04-20 | US |
| (72) |
SINGER, Robert, Alan, Pfizer Global Rch. and Dev., US
MCKINLEY, Jason Daniel, Pfizer Global Rch. and Dev, US
|
| (73) |
Pfizer Products Inc.,
Eastern Point Road, Groton, CT 06340,
US
|
| (54) | PROCESS FOR THE PREPARATION OF 1,3-SUBSTITUTED INDENES AND ARYL-FUSED AZAPOLYCYCLIC COMPOUNDS |
| PROCESS FOR THE PREPARATION OF 1,3-SUBSTITUTED INDENES AND ARYL-FUSED AZAPOLYCYCLIC COMPOUNDS |